Patents by Inventor Ismo RÅMAN

Ismo RÅMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MMP-8 activation product, its determination and use
    Patent number: 11378579
    Abstract: The present invention relates to a novel MMP-8 activation product such as a MMP-8 middle-part activation product. The invention also relates to detecting such a MMP-8 activation product or activated MMP-8 fragments in a biological sample derived from a subject and to the use thereof for diagnosing diseases which relate to abnormal or elevated levels of activated MMP-8.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: July 5, 2022
    Assignees: Oy Medix Biochemica AB, Dentognostics GmbH
    Inventors: Timo Sorsa, Dirk-Rolf Gieselmann, Armi Korvuo, Kurt Maier, Païvi Mäntylä, Ismo Råman, Sinikka Tiisala
  • MMP-8 ACTIVATION PRODUCT, ITS DETERMINATION AND USE
    Publication number: 20200064346
    Abstract: The present invention relates to a novel MMP-8 activation product such as a MMP-8 middle-part activation product. The invention also relates to detecting such a MMP-8 activation product or activated MMP-8 fragments in a biological sample derived from a subject and to the use thereof for diagnosing diseases which relate to abnormal or elevated levels of activated MMP-8.
    Type: Application
    Filed: May 2, 2019
    Publication date: February 27, 2020
    Inventors: Timo SORSA, DIRK-ROLF GIESELMANN, ARMI KORVUO, KURT MAIER, PÄIVI MÄNTYLÄ, ISMO RÅMAN, SINIKKA TIISALA
  • MMP-8 activation product, its determination and use
    Patent number: 10488415
    Abstract: MMP-8 activation products are disclosed that have a MMP-8 middle-part activation product having a size between 20-35 kDa. Methods of detecting the MMP-8 activation product or activated MMP-8 fragments in a biological sample derived from a subject are also disclosed. The MMP-8 activation product or activated MMP-8 fragments diagnose diseases based on abnormal or elevated levels of activated MMP-8.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: November 26, 2019
    Assignees: OY MEDIX BIOCHEMICA AB, DENTOGNOSTICS GMBH
    Inventors: Timo Sorsa, Dirk-Rolf Gieselmann, Armi Korvuo, Kurt Maier, Päivi Mäntylä, Ismo Råman, Sinikka Tiisala
  • MMP-8 activation product, its determination and use
    Patent number: 10330681
    Abstract: MMP-8 activation products are disclosed that have a MMP-8 middle-part activation product having a size between 20-35 kDa. Methods of detecting the MMP-8 activation product or activated MMP-8 fragments in a biological sample derived from a subject are also disclosed. The MMP-8 activation product or activated MMP-8 fragments diagnose diseases based on abnormal or elevated levels of activated MMP-8.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: June 25, 2019
    Assignees: OY MEDIX BIOCHEMICA AB, DENTOGNOSTICS GMBH
    Inventors: Timo Sorsa, Dirk-Rolf Gieselmann, Armi Korvuo, Kurt Maier, Päivi Mäntylä, Ismo Råman, Sinikka Tiisala
  • MMP-8 ACTIVATION PRODUCT, ITS DETERMINATION AND USE
    Publication number: 20170023571
    Abstract: MMP-8 activation products are disclosed that have a MMP-8 middle-part activation product having a size between 20-35 kDa. Methods of detecting the MMP-8 activation product or activated MMP-8 fragments in a biological sample derived from a subject are also disclosed. The MMP-8 activation product or activated MMP-8 fragments diagnose diseases based on abnormal or elevated levels of activated MMP-8.
    Type: Application
    Filed: February 27, 2015
    Publication date: January 26, 2017
    Inventors: Timo SORSA, Dirk-Rolf GIESELMANN, Armi KORVUO, Kurt MAIER, Päivi MÄNTYLÄ, Ismo RÅMAN, Sinikka TIISALA